Total Payments
$360.28
2023 Payments
$20.35
Companies
5
Transactions
16
Medicare Patients
2,311
Medicare Billing
$350,323
Payment Breakdown by Category
Food & Beverage$360.28 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $360.28 | 16 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Avanir Pharmaceuticals, Inc. | $166.83 | 5 | $0 (2022) |
| Lilly USA, LLC | $141.69 | 7 | $0 (2023) |
| UROVANT SCIENCES INC | $18.73 | 1 | $0 (2021) |
| Sunovion Pharmaceuticals Inc. | $17.67 | 2 | $0 (2018) |
| SANOFI-AVENTIS U.S. LLC | $15.36 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $20.35 | 1 | Lilly USA, LLC ($20.35) |
| 2022 | $67.81 | 3 | Lilly USA, LLC ($45.68) |
| 2021 | $18.73 | 1 | UROVANT SCIENCES INC ($18.73) |
| 2019 | $32.17 | 2 | Avanir Pharmaceuticals, Inc. ($32.17) |
| 2018 | $152.02 | 5 | Avanir Pharmaceuticals, Inc. ($112.53) |
| 2017 | $69.20 | 4 | Lilly USA, LLC ($53.84) |
All Payment Transactions
16 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/07/2023 | Lilly USA, LLC | BASAGLAR (Drug), TRULICITY | Food and Beverage | In-kind items and services | $20.35 | General |
| Category: Diabetes | ||||||
| 08/26/2022 | Lilly USA, LLC | BASAGLAR (Drug), TRULICITY, HUMALOG | Food and Beverage | In-kind items and services | $24.34 | General |
| Category: Diabetes | ||||||
| 08/11/2022 | Avanir Pharmaceuticals, Inc. | Nuedexta (Drug) | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 03/18/2022 | Lilly USA, LLC | BAQSIMI (Drug), TRULICITY | Food and Beverage | In-kind items and services | $21.34 | General |
| Category: Diabetes | ||||||
| 11/19/2021 | UROVANT SCIENCES INC | GEMTESA (Drug) | Food and Beverage | Cash or cash equivalent | $18.73 | General |
| Category: Urology | ||||||
| 09/26/2019 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 09/04/2019 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 07/26/2018 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $93.20 | General |
| Category: pseudobulbar affect PBA | ||||||
| 02/23/2018 | Sunovion Pharmaceuticals Inc. | UTIBRON (Drug) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: RESPIRATORY | ||||||
| 02/06/2018 | Lilly USA, LLC | TRULICITY (Drug), BASAGLAR | Food and Beverage | In-kind items and services | $21.82 | General |
| Category: Diabetes | ||||||
| 02/02/2018 | Sunovion Pharmaceuticals Inc. | UTIBRON (Drug) | Food and Beverage | In-kind items and services | $1.31 | General |
| Category: RESPIRATORY | ||||||
| 01/25/2018 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: pseudobulbar affect PBA | ||||||
| 09/29/2017 | Lilly USA, LLC | TRULICITY (Drug), BASAGLAR | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: Diabetes | ||||||
| 08/03/2017 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: DIABETES | ||||||
| 02/13/2017 | Lilly USA, LLC | HUMALOG (Drug), BASAGLAR | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: Diabetes | ||||||
| 01/10/2017 | Lilly USA, LLC | HUMALOG (Drug), BASAGLAR | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 469 | 769 | $146,302 | $77,448 |
| 2022 | 5 | 421 | 666 | $122,994 | $58,881 |
| 2021 | 7 | 691 | 1,265 | $225,885 | $103,444 |
| 2020 | 5 | 730 | 1,302 | $236,909 | $110,550 |
Total Patients
2,311
Total Services
4,002
Medicare Billing
$350,323
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 148 | 357 | $51,765 | $28,207 | 54.5% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 200 | 212 | $59,360 | $28,196 | 47.5% |
| 99310 | Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Office | 2023 | 90 | 162 | $29,889 | $18,802 | 62.9% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 19 | 25 | $2,363 | $1,293 | 54.7% |
| G0182 | Physician supervision of a patient under a medicare-approved hospice (patient not present) requiring complex and multidisciplinary care modalities involving regular physician development and/or revision of care plans, review of subsequent reports of patien | Office | 2023 | 12 | 13 | $2,925 | $949.92 | 32.5% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Facility | 2022 | 159 | 169 | $47,320 | $20,909 | 44.2% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Office | 2022 | 145 | 309 | $44,805 | $20,646 | 46.1% |
| 99310 | Follow-up nursing facility visit per day, typically 35 minutes | Office | 2022 | 73 | 134 | $24,723 | $13,673 | 55.3% |
| 99358 | Extended patient service without direct patient contact, first hour | Office | 2022 | 26 | 29 | $3,784 | $2,453 | 64.8% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Office | 2022 | 18 | 25 | $2,363 | $1,200 | 50.8% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Office | 2021 | 227 | 653 | $94,685 | $40,204 | 42.5% |
| 99306 | Initial nursing facility visit, typically 45 minutes per day | Facility | 2021 | 260 | 280 | $78,400 | $35,196 | 44.9% |
| 99310 | Subsequent nursing facility visit, typically 35 minutes per day | Office | 2021 | 97 | 194 | $35,793 | $19,774 | 55.2% |
| 99358 | Prolonged patient service without direct patient contact first hour | Office | 2021 | 43 | 53 | $6,095 | $4,213 | 69.1% |
| G0182 | Physician supervision of a patient under a medicare-approved hospice (patient not present) requiring complex and multidisciplinary care modalities involving regular physician development and/or revision of care plans, review of subsequent reports of patien | Office | 2021 | 21 | 22 | $4,950 | $1,782 | 36.0% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Office | 2021 | 26 | 46 | $4,347 | $1,580 | 36.3% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2021 | 17 | 17 | $1,615 | $694.11 | 43.0% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Office | 2020 | 261 | 690 | $100,050 | $45,890 | 45.9% |
| 99306 | Initial nursing facility visit, typically 45 minutes per day | Facility | 2020 | 291 | 311 | $87,080 | $39,021 | 44.8% |
| 99310 | Subsequent nursing facility visit, typically 35 minutes per day | Office | 2020 | 109 | 195 | $35,978 | $19,936 | 55.4% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Office | 2020 | 40 | 77 | $7,277 | $3,526 | 48.5% |
| G0182 | Physician supervision of a patient under a medicare-approved hospice (patient not present) requiring complex and multidisciplinary care modalities involving regular physician development and/or revision of care plans, review of subsequent reports of patien | Office | 2020 | 29 | 29 | $6,525 | $2,178 | 33.4% |
About Dr. Farasat Ashraf, M.D
Dr. Farasat Ashraf, M.D is a Specialist healthcare provider based in Zebulon, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/01/2005. The National Provider Identifier (NPI) number assigned to this provider is 1841297082.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Farasat Ashraf, M.D has received a total of $360.28 in payments from pharmaceutical and medical device companies, with $20.35 received in 2023. These payments were reported across 16 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($360.28).
As a Medicare-enrolled provider, Ashraf has provided services to 2,311 Medicare beneficiaries, totaling 4,002 services with total Medicare billing of $350,323. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Location Zebulon, NC
- Active Since 07/01/2005
- Last Updated 05/14/2009
- Taxonomy Code 174400000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1841297082
Products in Payments
- NUEDEXTA (Drug) $144.70
- BASAGLAR (Drug) $44.69
- TRULICITY (Drug) $40.58
- HUMALOG (Drug) $35.08
- Nuedexta (Drug) $22.13
- BAQSIMI (Drug) $21.34
- GEMTESA (Drug) $18.73
- UTIBRON (Drug) $17.67
- TOUJEO (Drug) $15.36
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.